Scilex Holding Company announced its board approved a dividend distribution of Semnur Pharmaceuticals common stock to Scilex shareholders and eligible equity holders. For each share of Scilex common stock held as of June 1, 2026, shareholders will receive one share of Semnur stock. Scilex holds about 186 million Semnur shares and plans to distribute approximately 10.7 million shares. The dividend payment date will be set within 60 days after the record date, subject to board approval and potential changes. This move reflects Scilex's strategy to reward shareholders with equity in its majority-owned subsidiary focused on non-opioid pain therapies.
The Low Earth Orbit (LEO) satellite market is projected to expand significantly, reaching a valuation of $74.54 billion by 2035 from $15.77 billion in 2025, with a CAGR of 16.8%. Growth is fueled by rising demand for broadband in underserved areas, c...
During week 21 of 2026 (May 18-22), Sampo Oyj bought back a total of 1,911,568 of its own A-shares across multiple exchanges at a weighted average price of €9.21 per share. This buyback is part of a program authorized by the company's annual general ...
Ericsson has announced plans to relocate its Stockholm headquarters and operations from Kista to Hagastaden, aiming to create a modern office campus that fosters collaboration and attracts talent. The move will begin in early 2028 and is expected to ...
Bitcoin ended last week slightly down despite volatile swings caused by Nvidia earnings, Federal Reserve leadership changes, and US-Iran tensions. Optimism rose after Donald Trump hinted at a quick resolution to the Iran conflict, easing fears of pro...
V2X presents a unique buying opportunity now that a two-year private equity overhang has ended, which previously suppressed open market demand by allowing institutions to buy shares at a discount. The company shows growing revenues, a record backlog,...
